TrialAnnals of hematology2026

Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 study.

Hongyan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.